"10.1371_journal.pone.0120096","plos one","2015-04-07T00:00:00Z","Fay Saunders; Berni Sweeney; Michael N Antoniou; Paul Stephens; Katharine Cain","Protein Expression and Purification Group, UCB, Slough, Berkshire, United Kingdom; Gene Expression and Therapy Group, Kings College School of Medicine, Department of Molecular Genetics, Guys Hospital, London Bridge, London, United Kingdom","Conceived and designed the experiments: FS MA PS. Performed the experiments: FS. Analyzed the data: FS PS MA BS KC. Contributed reagents/materials/analysis tools: FS BS MA. Wrote the paper: KC.","This study was funded by UCB Pharma. Katharine Cain, Bernie Sweeney and Paul Stephens are full time employees of UCB Pharma. Fay Saunders (currently employed by Fujifilm Diosynth Biotechnologies) contributed to this work whilst an employee of UCB Pharma. Michael Antoniou has a holding inventor status on patents granted in all major territories covering the biotechnological applications of UCOEs (including for example, Polynucleotide, patent numbers: US 6,689,606 B2; EP99934910.3; Korea 2003-7004014; Japan 2008-243399; International PCT WO 00/05393; Artificial UCOE, International PCT WO 02/024930 A3; EP01 969 944.6-2401). This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Fay Saunders","FS",5,TRUE,3,1,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
